Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating Expenses:        
Research and development expenses $ 1,200,127 $ 2,319,049 $ 1,796,468 $ 4,370,672
General and administrative expenses 2,630,335 2,084,676 5,092,948 4,873,387
Total Operating Expenses 3,830,462 4,403,725 6,889,416 9,244,059
Loss From Operations (3,830,462) (4,403,725) (6,889,416) (9,244,059)
Other Income (Expense)        
Interest income 6,930 1,181 12,045 1,476
Change in value of contingent liability (24,000) (67,478) 122,000 (61,203)
Other income 29,088 29,088
Total other income (expense) (17,070) (37,209) 134,045 (30,639)
Loss Before Provision For Income Taxes (3,847,532) (4,440,934) (6,755,371) (9,274,698)
Provision for income taxes
Net Loss $ (3,847,532) $ (4,440,934) $ (6,755,371) $ (9,274,698)
Net loss per share, basic (in Dollars per share) $ (0.16) $ (0.25) $ (0.29) $ (0.55)
Weighted average shares, basic (in Shares) 24,316,031 17,588,840 23,330,652 16,854,425